Primary record
Sacubitril Valsartan Sodium intermediate I (2R,4S)-5-((1,1'-BIPHENYL)-4-YL)-4-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPENTANOIC ACID
- 库存
- 9,744 克
- 纯度
- 98.6 %
- CAS
- 1012341-50-2
化合物标识与属性
- CAS
- 1012341-50-2
- PubChem CID
- 46193546
- SMILES
- C[C@H](C[C@@H](CC1=CC=C(C=C1)C2=CC=CC=C2)NC(=O)OC(C)(C)C)C(=O)O
- Canonical SMILES
- C[C@H](C[C@@H](Cc1ccc(-c2ccccc2)cc1)NC(=O)OC(C)(C)C)C(=O)O
名称与同义词
- 1012341-50-2
- (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid
- FJ7AWX8DMF
- Valsartan Impurity 80
- UNII-FJ7AWX8DMF
- MFCD27955981
- Valsartan Impurity 124
- RefChem:397629
- LCZ-696 Intermediate 40
- C23H29NO4
- SCHEMBL597902
- YNELJETWNMPEEH-UZLBHIALSA-N
- AMBZ0395
- KS-00000SUS
- DTXSID001123526
- AKOS027324883
- ZINC112971388
- ACN-036826
- AM85444
- CS-O-13858
- (2R,4S)-5-(Biphenyl-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
- (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methylpentanoic acid
- AC-28990
- DS-11562
- SY116136
- DB-335942
- CS-0009331
- J3.128.635B
- [1,1'-Biphenyl]-4-pentanoic acid, gamma-[[(1,1-dimethylethoxy)carbonyl]amino]-alpha-methyl-, (alphaR,gammaS)-
- (2R,4S)-2-methyl-4-[(2-methylpropan-2-yl)oxycarbonylamino]-5-(4-phenylphenyl)pentanoic acid
- A854795
- F470018
- (2R,4S)-5-(4-Biphenylyl)-4-(Boc-amino)-2-methylpentanoic Acid
- (2R,4S)-5-([1,1-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoic acid
- B1604-479394
- (2R,4S)-5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid
- (2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid
- (2R,4S)-5-biphenyl-4-yl-4-tert-butoxycarbonylamino-2-methyl-pentanoic acid
- (2R,4S)-2-Methyl-4-[(tert-butyloxycarbonyl)amino]-5-(biphenyl-4-yl)pentanoic acid
- (2R,4S)-4-(tert-butoxycarbonylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid
- (2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)aMino)-2-Methylpentanoicacid
- (2R,4S)-5-(Biphenyl-4-yl)-4-(tert-butoxycarbonylamino)-2-methylpentanoic acid
- (2R,4S)-5-{[1,1'-biphenyl]-4-yl}-4-{[(tert-butoxy)carbonyl]amino}-2-methylpentanoic acid
- (1,1'-Biphenyl)-4-pentanoic acid, gamma-(((1,1-dimethylethoxy)carbonyl)amino)-alpha-methyl-, (alphaR,gammaS)-
- (2R,4S)-2-methyl-4-((2-methylpropan-2-yl)oxycarbonylamino)-5-(4-phenylphenyl)pentanoic acid
- (2R,4S)-5-(4-Biphenylyl)-2-methyl-4-({[(2-methyl-2-propanyl)oxy]carbonyl}amino)pentanoic acid
- (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2- methylpentanoic acid ethyl ester
- (alphaR,gammaS)-gamma-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-methyl[1,1'-biphenyl]-4-pentanoic acid
- (alphaR,gammaS)-gamma-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-methyl[1,1'-biphenyl]-4-pentanoic Acid;
- (I+/-R,I(3)S)-I(3)-[[(1,1-Dimethylethoxy)carbonyl]amino]-I+/--methyl[1,1a(2)-biphenyl]-4-pentanoic acid
- [1,1'-Biphenyl]-4-pentanoic acid, |A-[[(1,1-dimethylethoxy)carbonyl]amino]-|A-methyl-, (|AR,|AS)-
- 5-((1,1'-Biphenyl)-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpentanoic acid, (2R,4S)-
- 5-([1,1'-Biphenyl]-4-yl)-4-[(tert-butoxycarbonyl)amino]-2-methylpentanoic acid, (2R,4S)-
- 695-674-1
- gamma-[[(1,1-Dimethylethoxy)carbonyl]amino]-alpha-methyl[1,1'-biphenyl]-4-pentanoic acid, (alphaR,gammaS)-
- Sacubitril Valsartan Sodium intermediate I (2R,4S)-5-((1,1'-BIPHENYL)-4-YL)-4-((TERT-BUTOXYCARBONYL)AMINO)-2-METHYLPENTANOIC ACID